131 related articles for article (PubMed ID: 33340712)
81. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy.
Link P; Freiha FS; Stamey TA
J Urol; 1991 Mar; 145(3):532-4. PubMed ID: 1705294
[TBL] [Abstract][Full Text] [Related]
82. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
Partin AW; Pearson JD; Landis PK; Carter HB; Pound CR; Clemens JQ; Epstein JI; Walsh PC
Urology; 1994 May; 43(5):649-59. PubMed ID: 7513108
[TBL] [Abstract][Full Text] [Related]
83. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
84. The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance.
Monfared S; Fleishman A; Korets R; Chang P; Wagner A; Bubley G; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2021 Nov; 39(11):783.e21-783.e30. PubMed ID: 33992521
[TBL] [Abstract][Full Text] [Related]
85. The prognostic value of pathologic prostate-specific antigen mass ratio in patients with localized prostate cancer with negative surgical resection margins.
Lee S; Jeong CW; Jeong SJ; Hong SK; Choi W; Byun SS; Lee SE
Urology; 2013 Oct; 82(4):865-9. PubMed ID: 23830078
[TBL] [Abstract][Full Text] [Related]
86. Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.
Fossati N; Robesti D; Karnes RJ; Soligo M; Boorjian SA; Bossi A; Coraggio G; Di Muzio N; Cozzarini C; Noris Chiorda B; Gandaglia G; Scarcella S; Bartkowiak D; Böhmer D; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Wiegel T; Briganti A
Eur Urol; 2019 Oct; 76(4):443-449. PubMed ID: 30799187
[TBL] [Abstract][Full Text] [Related]
87. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
King CR; Presti JC; Gill H; Brooks J; Hancock SL
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
[TBL] [Abstract][Full Text] [Related]
88. Characterising potential bone scan overuse amongst men treated with radical prostatectomy.
Kirk PS; Borza T; Caram MEV; Shumway DA; Makarov DV; Burns JA; Shelton JB; Leppert JT; Chapman C; Chang M; Hollenbeck BK; Skolarus TA
BJU Int; 2019 Jul; 124(1):55-61. PubMed ID: 30246937
[TBL] [Abstract][Full Text] [Related]
89. Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up.
Gleave ME; La Bianca SE; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
Urology; 2000 Aug; 56(2):289-94. PubMed ID: 10925096
[TBL] [Abstract][Full Text] [Related]
90. Prostate specific antigen only progression of prostate cancer.
Moul JW
J Urol; 2000 Jun; 163(6):1632-42. PubMed ID: 10799151
[TBL] [Abstract][Full Text] [Related]
91. Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer.
Kim DW; Chen MH; Wu J; Huland H; Graefen M; Tilki D; D'Amico AV
Cancer; 2021 Jul; 127(13):2222-2228. PubMed ID: 34101827
[TBL] [Abstract][Full Text] [Related]
92. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
[No Abstract] [Full Text] [Related]
93. Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature.
Ploussard G; Fossati N; Wiegel T; D'Amico A; Hofman MS; Gillessen S; Mottet N; Joniau S; Spratt DE
Eur Urol Oncol; 2021 Apr; 4(2):150-169. PubMed ID: 33574012
[TBL] [Abstract][Full Text] [Related]
94. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
Meijer D; Luiting HB; van Leeuwen PJ; Remmers S; Jansen BHE; Bodar YJL; Witteveen T; Schaake EE; van der Poel HG; Wondergem M; Busstra MB; Nieuwenhuijzen JA; Meijnen P; Brabander T; van Moorselaar RJA; Hendrikse NH; Oprea-Lager DE; Roobol MJ; Vis AN
J Urol; 2021 Apr; 205(4):1100-1109. PubMed ID: 33207138
[TBL] [Abstract][Full Text] [Related]
95. Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.
Goris Gbenou MC; Peltier A; Schulman CC; Velthoven Rv
Urol Oncol; 2016 Jun; 34(6):254.e1-6. PubMed ID: 26822075
[TBL] [Abstract][Full Text] [Related]
96. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
[TBL] [Abstract][Full Text] [Related]
97. Local Treatment and Treatment-Related Adverse Effects Among Patients With Advanced Prostate Cancer.
Khan S; Chang SH; Wang M; Kim EH; Schoen MW; Rocuskie-Marker C; Drake BF
JAMA Netw Open; 2023 Dec; 6(12):e2348057. PubMed ID: 38109113
[TBL] [Abstract][Full Text] [Related]
98. Association of travel distance, surgical volume, and receipt of adjuvant chemotherapy with survival among patients with resectable lung cancer.
Logan CD; Ellis RJ; Feinglass J; Halverson AL; Avella D; Lung K; Kim S; Bharat A; Merkow RP; Bentrem DJ; Odell DD
JTCVS Open; 2023 Mar; 13():357-378. PubMed ID: 37063116
[TBL] [Abstract][Full Text] [Related]
99. Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.
Eisenberg MA; Deboever N; Mills AC; Egyud MR; Hofstetter WL; Mehran RJ; Rice DC; Rajaram R; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB
J Thorac Cardiovasc Surg; 2024 May; 167(5):1617-1627. PubMed ID: 37696428
[TBL] [Abstract][Full Text] [Related]
100. Association Between Distance to an Abortion Facility and Abortion or Pregnancy Outcome Among a Prospective Cohort of People Seeking Abortion Online.
Pleasants EA; Cartwright AF; Upadhyay UD
JAMA Netw Open; 2022 May; 5(5):e2212065. PubMed ID: 35560050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
